The results of the present study indicate that both a 5-HT2A antagonist and 5-HT1A agonist are good enough in ameliorating ADHD symptoms by indirectly acting on DA-D1 and DA-D2 receptors in spontaneously hypertensive rats. The gene discussed is HTR2A; the disease is attention deficit-hyperactivity disorder.